Article

Clinicians take heed with new glaucoma procedures

Los Angeles-Considering the limited availability of published randomized trials, glaucoma surgeons should remain skeptical about the safety and efficacy of viscocanalostomy and deep sclerectomy with collagen wick, said Donald S. Minckler, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
(Image credit: SeeWhatMatters)
August 22nd 2025

Q&A: AEVR's executive director on #SeeWhatMatters and safeguarding the National Eye Institute

3 Things You Should Know About the GA Pipeline
August 22nd 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/InkInvent) FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
August 22nd 2025

FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 22nd 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 22nd 2025

Robotic precision: Elevating the state of laser cataract surgery

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 22nd 2025

AI applications in cataract surgery: A surgeon’s perspective

© 2025 MJH Life Sciences

All rights reserved.